← FDA Drug Approvals (Drugs@FDA)
CIMERLI
BLA · Biologics License Application · Sponsor: SANDOZ INC · Approved 2022-08-02
Drug application
- FDA Application #
BLA761165- Application type
- Biologics License Application
- Brand name
- CIMERLI
- Generic name
- RANIBIZUMAB-EQRN
- Active ingredients
- RANIBIZUMAB-EQRN
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- SANDOZ INC
- Manufacturer
- Coherus BioSciences Inc
- First approval
- 2022-08-02
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown